医薬品開発業務受託機関（CRO）サービスの世界市場

Report Highlights

The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

医薬品開発業務受託機関（CRO）サービスの世界市場は、2024 年の 1,118 億ドルから成長し、2029 年末までに 1,660 億ドルに達すると予測されています。2024 年から 2029 年の予測期間中、年平均成長率 (CAGR) は 8.2% となります。

Summary:

Contract research organizations play a crucial role in the biotech, pharmaceutical and medical industries as they help their clients conduct clinical trials focused on the development of new medications and medical devices. CROs offer full drug development capabilities, enabling organizations to quickly and economically navigate regulatory and market access barriers. Ultimately, this helps reduce costs in specialized markets.

The global CRO market’s value has surged due to increased outsourcing resulting from three main factors: specialized demand, patent expiration and the rise of generic drugs. Pharmaceutical companies are looking for ways to achieve cost savings and efficiency in clinical trials, which is causing increased time-to-market pressures and margin awareness. This integrated pharma-CRO partnership results in efficiency gains, making it ideal for clinical trials with high complexity, strict timelines or broad scope.

Presently, pharma pipelines are full with advanced treatments, including regenerative cell-based therapies, CAR-T, immune-oncology combinations and autoimmune therapies. Clinical trials that utilize advanced data and analytics to enhance adaptive trial designs and patient selection, and thereby ensure the development of cutting-edge treatments for market release, are underway worldwide. Adaptive design and risk-based monitoring in studies can reduce costs and allow for adjustments as research progresses. These methods improve drug discovery, patient safety and reduce risks for patients and pharmaceutical companies. As a result, patient receptivity is high, and this is leading to the rapid growth of clinical trials globally.

Increasing numbers of chronic diseases and rising drug discovery are also boosting the growth. Chronic disease affects hundreds of millions of patients globally. Approximately 45% of the population of the Americas, or 133 million people, suffer from one or more chronic health condition. Similarly, in Europe, nearly 60 million people have more than one chronic disease. The prevalence of chronic disease is expected to rise rapidly in the forecast period (2024–2029), and this is expected to create a significant burden on global healthcare.

This unprecedented release of drugs in the market by wealthy pharmaceutical companies, is benefitting CROs. These organizations are leveraging their experience in specific clinical research phases to capitalize on the increasing importance of cost-effectiveness and time-to-market acceleration in the competitive and time-sensitive drug development market.

Report Scope

This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.

As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.

The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.

This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market’s competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.

Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.

This report’s goals include:

– Analyzing technologies and applications.

– Analyzing global market size and segmentation.

– Understanding market constraints and drivers.

– Providing detailed market forecasts through 2029.

– Assessing market shares, competitiveness and industry structure.

– Identifying potential long-term impacts on the CRO services market.

Report Synopsis

Report Includes

– 86 data tables and 33 additional tables

– An overview of the current and future global market for contract research organization (CRO) services

– Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029

– Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region

– Information on CDISC standards, and regulations on sponsor activities; discussion of the  impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market

– Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies

– Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes

– Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding

– Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of the Report

Market Summary

Chapter 2 Market Overview

Overview

Porter’s Five Forces Analysis

Bargaining Power of Buyers

Bargaining Power of Suppliers

Potential for New Entrants

Threat of Substitutes

Competitiveness in the Industry

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Increasing Adoption of AI in CROs

R&D Investment in Biotech & Pharma Companies

Rising Prevalence of Chronic and Immunological Diseases Globally

CROs Add Efficiency

Market Restraints

Challenges in CRO Outsourcing

Shortage of Skilled Professionals

Market Opportunities

Inorganic Strategies

Chapter 4 Regulatory Landscape

FDA Regulation and Impact

Regulations on Sponsor Activities

CDISC Standards

BIMO Program

European Standards

Chapter 5 Emerging Technologies

Overview

Computer-Based Techniques

Decentralized Clinical Trials

Advanced Analytics and Simulation

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown

Global Market CRO Services by Functional Services

Global Market Size and Forecast

Clinical Trials

Preclinical Research

Drug Discovery

Central Lab

Global Market for CRO Services by Therapeutic Area

Global Market Size and Forecast

Oncology

Cardiology

Metabolic

Neurology

Immunology

Other Applications

Global Market for CRO Services, by End User

Global Market Size and Forecast

Biopharmaceutical Companies

Academic Research Institutions

Geographic Breakdown

Global Market for CRO Services by Region

Global Market Size and Forecast

North America

Europe

Asia-Pacific

Rest of World

Chapter 7 Competitive Intelligence

Overview

Competitive Landscape

Mergers and Acquisitions

SWOT Analysis

Strengths of the Global Market for CRO Services

Weaknesses of the Global Market for CRO Services

Opportunities in the Global Market for CRO Services

Threats to the Global Market for CRO Services

Chapter 8 Sustainability in CRO Services Market: An ESG Perspective

Introduction to ESG

Sustainability in the CRO Services Market

ESG Perspective

Environmental Impact

Social Impact

Governance

Chapter 9 Appendix

Methodology

Abbreviations

Sources

Company Profiles

CHARLES RIVER LABORATORIES

FRONTAGE LABS.

ICON PLC

IQVIA INC.

LABORATORY CORPORATION OF AMERICA HOLDINGS

MEDPACE

PAREXEL INTERNATIONAL CORP.

SYNEOS HEALTH

THERMO FISHER SCIENTIFIC INC.

WUXI APPTEC

List of Tables

Summary Table : Global Market for CRO Services, by Functional Services, Through 2029

Table 1 : Summary of Porter’s Five Forces Analysis: CRO Services Market

Table 2 : Global Market for CRO Services, by Functional Services, Through 2029

Table 3 : Clinical Trail Illustration

Table 4 : Clinical Trial Phase Description

Table 5 : Global Market for CRO Services in Clinical Trials, by Region, Through 2029

Table 6 : Global Market for CRO Services in Preclinical Research, by Region, Through 2029

Table 7 : Global Market for CRO Services in Drug Discovery, by Region, Through 2029

Table 8 : Global Market for CRO Services in Central Laboratories, by Region, Through 2029

Table 9 : Global Market for CRO Services, by Therapeutic Area, Through 2029

Table 10 : Global Market for CRO Services in Oncology, by Region, Through 2029

Table 11 : Global Market for CRO Services in Cardiology, by Region, Through 2029

Table 12 : Global Market for CRO Services in Metabolic Diseases, by Region, Through 2029

Table 13 : Global Market for CRO Services in Neurology, by Region, Through 2029

Table 14 : Global Market for CRO Services in Immunological Disorders, by Region, Through 2029

Table 15 : Global Market for CRO Services in Other Therapeutic Areas, by Region, Through 2029

Table 16 : Global Market for CRO Services, by End User, Through 2029

Table 17 : Global Market for CRO Services in Biopharmaceutical Companies, by Region, Through 2029

Table 18 : Global Market for CRO Services in Academic Research Institutions, by Region, Through 2029

Table 19 : Global Market for CRO Services, by Region, Through 2029

Table 20 : Diabetes Estimates in North America, by Country, 2000–2045

Table 21 : North American Market for CRO Services, by Functional Services, Through 2029

Table 22 : North American Market for CRO Services, by Therapeutic Area, Through 2029

Table 23 : North American Market for CRO Services, by End User, Through 2029

Table 24 : North American Market for CRO Services, by Country, Through 2029

Table 25 : U.S. Market for CRO Services, by Functional Services, Through 2029

Table 26 : U.S. Market for CRO Services, by Therapeutic Area, Through 2029

Table 27 : U.S. Market for CRO Services, by End User, Through 2029

Table 28 : Canadian Market for CRO Services, by Functional Services, Through 2029

Table 29 : Canadian Market for CRO Services, by Therapeutic Area, Through 2029

Table 30 : Canadian Market for CRO Services, by End User, Through 2029

Table 31 : Mexican Market for CRO Services, by Functional Services, Through 2029

Table 32 : Mexican Market for CRO Services, by Therapeutic Area, Through 2029

Table 33 : Mexican Market for CRO Services, by End User, Through 2029

Table 34 : Diabetes Estimates for the Top 10 European Countries, 2000–2045

Table 35 : European Market for CRO Services, by Functional Services, Through 2029

Table 36 : European Market for CRO Services, by Therapeutic Area, Through 2029

Table 37 : European Market for CRO Services, by End User, Through 2029

Table 38 : European Market for CRO Services, by Country, Through 2029

Table 39 : German Market for CRO Services, by Functional Services, Through 2029

Table 40 : German Market for CRO Services, by Therapeutic Area, Through 2029

Table 41 : German Market for CRO Services, by End User, Through 2029

Table 42 : U.K. Market for CRO Services, by Functional Services, Through 2029

Table 43 : U.K. Market for CRO Services, by Therapeutic Area, Through 2029

Table 44 : U.K. Market for CRO Services, by End User, Through 2029

Table 45 : French Market for CRO Services, by Functional Services, Through 2029

Table 46 : French Market for CRO Services, by Therapeutic Area, Through 2029

Table 47 : French Market for CRO Services, by End User, Through 2029

Table 48 : Rest of the European Market for CRO Services, by Functional Services, Through 2029

Table 49 : Rest of the European Market for CRO Services, by Therapeutic Area, Through 2029

Table 50 : Rest of the European Market for CRO Services, by End User, Through 2029

Table 51 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000–2045

Table 52 : Asia-Pacific Market for CRO Services, by Functional Services, Through 2029

Table 53 : Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029

Table 54 : Asia-Pacific Market for CRO Services, by End User, Through 2029

Table 55 : Asia-Pacific Market for CRO Services, by Country, Through 2029

Table 56 : Chinese Market for CRO Services, by Functional Services, Through 2029

Table 57 : Chinese Market for CRO Services, by Therapeutic Area, Through 2029

Table 58 : Chinese Market for CRO Services, by End User, Through 2029

Table 59 : Japanese Market for CRO Services, by Functional Services, Through 2029

Table 60 : Japanese Market for CRO Services, by Therapeutic Area, Through 2029

Table 61 : Japanese Market for CRO Services, by End User, Through 2029

Table 62 : Indian Market for CRO Services, by Functional Services, Through 2029

Table 63 : Indian Market for CRO Services, by Therapeutic Area, Through 2029

Table 64 : Indian Market for CRO Services, by End User, Through 2029

Table 65 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, Through 2029

Table 66 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029

Table 67 : Rest of Asia-Pacific Market for CRO Services, by End User, Through 2029

Table 68 : Rest of the World Market for CRO Services, by Functional Services, Through 2029

Table 69 : Rest of the World Market for CRO Services, by Therapeutic Area, Through 2029

Table 70 : Rest of the World Market for CRO Services, by End User, Through 2029

Table 71 : Rest of the World Market for CRO Services, by Sub-Region, Through 2029

Table 72 : South American Market for CRO Services, by Functional Services, Through 2029

Table 73 : South American Market for CRO Services, by Therapeutic Area, Through 2029

Table 74 : South American Market for CRO Services, by End User, Through 2029

Table 75 : Middle Eastern and African Market for CRO Services, by Functional Services, Through 2029

Table 76 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, Through 2029

Table 77 : Middle Eastern and African Market for CRO Services, by End User, Through 2029

Table 78 : Service Offerings, Major CROs

Table 79 : Pharmaceutical and CRO Partnership Alliances

Table 80 : Recent M&As in CROs Services Market, 2020–2024

Table 81 : Key ESG Metrics in the CRO Services Market

Table 82 : ESG Rankings for CRO Services

Table 83 : Abbreviations Used in this Report

Table 84 : Report Sources

Table 85 : Charles River Laboratories: Company Snapshot

Table 86 : Charles River Laboratories: Financial Performance, FY 2022 and 2023

Table 87 : Charles River Laboratories: Service Portfolio

Table 88 : Charles River Laboratories: News/Key Developments, 2021-2024

Table 89 : Frontage Labs.: Company Snapshot

Table 90 : Frontage Labs.: Financial Performance, FY 2022 and 2023

Table 91 : Frontage Labs.: Product Portfolio

Table 92 : Frontage Labs.: News/Key Development, 2022-2024

Table 93 : ICON plc: Company Snapshot

Table 94 : ICON plc: Financial Performance, FY 2022 and 2023

Table 95 : ICON plc: Product Portfolio

Table 96 : ICON plc: News/Key Development, 2020-2023

Table 97 : IQVIA Inc.: Company Snapshot

Table 98 : IQVIA Inc.: Financial Performance, FY 2022 and 2023

Table 99 : IQVIA Inc.: Service Portfolio

Table 100 : IQVIA Inc.: News/Key Developments, 2024

Table 101 : Laboratory Corporation of America Holdings: Company Snapshot

Table 102 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023

Table 103 : Laboratory Corporation of America Holdings: Service Portfolio

Table 104 : Laboratory Corporation of America Holdings: News/Key Developments, 2024

Table 105 : Medpace: Company Snapshot

Table 106 : Medpace: Financial Performance, FY 2022 and 2023

Table 107 : Medpace: Service Portfolio

Table 108 : Parexel International Corp.: Company Snapshot

Table 109 : Parexel International Corp.: Service Portfolio

Table 110 : Syneos Health: Company Snapshot

Table 111 : Syneos Health: Service Portfolio

Table 112 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 113 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 114 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 115 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023

Table 116 : WuXi AppTec: Company Snapshot

Table 117 : WuXi AppTec: Financial Performance, FY 2022 and 2023

Table 118 : WuXi AppTec: Service Portfolio

List of Figures

Summary Figure : Global Market for CRO Services, by Functional Services, 2021–2029

Figure 1 : CRO Services: Market Dynamics

Figure 2 : Global Market Shares of CRO Services, by Functional Services, 2023

Figure 3 : Overall Phase Transition Success Rates in Biologic Drug Development

Figure 4 : Phase II Transition Success Rates, by Disease Area, 2021

Figure 5 : Phase III Transition Success Rates, by Disease Area, 2021

Figure 6 : Global Market Shares of CRO Services Throughout the Clinical Trial Process, by Phase, 2023

Figure 7 : Phase IV Transition Success Rates, by Disease Area, 2021

Figure 8 : Global Market for CRO Services in Clinical Trials, by Region, 2021–2029

Figure 9 : Global Market for CRO Services in Preclinical Research, by Region, 2021–2029

Figure 10 : CRO Services Related to Drug Discovery

Figure 11 : Global Market for CRO Services in Drug Discovery, by Region, 2021–2029

Figure 12 : Global Market for CRO Services in Central Laboratories, by Region, 2021–2029

Figure 13 : Global Market Shares of CRO Services, by Therapeutic Area, 2023

Figure 14 : Global Market Shares of CRO Services in Oncology, by Region, 2023

Figure 15 : Global Market Shares of CRO Services in Cardiology, by Region, 2023

Figure 16 : Global Market Shares of CRO Services in Metabolic Diseases, by Region, 2023

Figure 17 : Global Market Shares of CRO Services in Neurology, by Region, 2023

Figure 18 : Global Market Shares of CRO Services in Immunological Disorders, by Region, 2023

Figure 19 : Global Market Shares of CRO Services in Other Therapeutic Areas, by Region, 2023

Figure 20 : Global Market Shares of CRO Services, by End User, 2023

Figure 21 : Global Market Shares of CRO Services in Biopharmaceutical companies, by Region, 2023

Figure 22 : Global Market Shares of CRO Services in Academic Research Institutions, by Region, 2023

Figure 23 : Global Market for CRO Services, by Region, 2021–2029

Figure 24 : North American Market for CRO Services, by Functional Services, 2021–2029

Figure 25 : North American Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 26 : North American Market for CRO Services, by End User, 2021–2029

Figure 27 : North American Market Shares of CRO Services, by Country, 2023

Figure 28 : U.S. Market for CRO Services, by Functional Services, 2021–2029

Figure 29 : U.S. Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 30 : U.S. Market for CRO Services, by End User, 2021–2029

Figure 31 : Canadian Market for CRO Services, by Functional Services, 2021–2029

Figure 32 : Canadian Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 33 : Canadian Market for CRO Services, by End User, 2021–2029

Figure 34 : Mexican Market for CRO Services, by Functional Services, 2021–2029

Figure 35 : Mexican Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 36 : Mexican Market for CRO Services, by End User, 2021–2029

Figure 37 : European Market for CRO Services, by Functional Services, 2021–2029

Figure 38 : European Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 39 : European Market for CRO Services, by End User, 2021–2029

Figure 40 : European Market Shares of CRO Services, by Country, 2023

Figure 41 : German Market for CRO Services, by Functional Services, 2021–2029

Figure 42 : German Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 43 : German Market for CRO Services, by End User, 2021–2029

Figure 44 : U.K. Market for CRO Services, by Functional Services, 2021–2029

Figure 45 : U.K. Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 46 : U.K. Market for CRO Services, by End User, 2021–2029

Figure 47 : French Market for CRO Services, by Functional Services, 2021–2029

Figure 48 : French Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 49 : French Market for CRO Services, by End User, 2021–2029

Figure 50 : Rest of the European Market for CRO Services, by Functional Services, 2021–2029

Figure 51 : Rest of the European Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 52 : Rest of the European Market for CRO Services, by End User, 2021–2029

Figure 53 : Asia-Pacific Market for CRO Services, by Functional Services, 2021–2029

Figure 54 : Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 55 : Asia-Pacific Market for CRO Services, by End User, 2021–2029

Figure 56 : Asia-Pacific Market Shares of CRO Services, by Country, 2023

Figure 57 : Chinese Market for CRO Services, by Functional Services, 2021–2029

Figure 58 : Chinese Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 59 : Chinese Market for CRO Services, by End User, 2021–2029

Figure 60 : Japanese Market for CRO Services, by Functional Services, 2021–2029

Figure 61 : Japanese Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 62 : Japanese Market for CRO Services, by End User, 2021–2029

Figure 63 : Indian Market for CRO Services, by Functional Services, 2021–2029

Figure 64 : Indian Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 65 : Indian Market for CRO Services, by End User, 2021–2029

Figure 66 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, 2021–2029

Figure 67 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 68 : Rest of Asia-Pacific Market for CRO Services, by End User, 2021–2029

Figure 69 : Rest of the World Market for CRO Services, by Functional Services, 2021–2029

Figure 70 : Rest of the World Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 71 : Rest of the World Market for CRO Services, by End User, 2021–2029

Figure 72 : Rest of the World Market Shares of CRO Services, by Sub-Region, 2023

Figure 73 : South American Market for CRO Services, by Functional Services, 2021–2029

Figure 74 : South American Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 75 : South American Market for CRO Services, by End User, 2021–2029

Figure 76 : Middle Eastern and African Market for CRO Services, by Functional Services, 2021–2029

Figure 77 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, 2021–2029

Figure 78 : Middle Eastern and African Market for CRO Services, by End User, 2021–2029

Figure 79 : Global Market Shares of CRO Services, by Company, 2020

Figure 80 : SWOT Analysis of the CRO Services Market

Figure 81 : Pillars of ESG

Figure 82 : Advantages of ESG for CRO Services Companies

Figure 83 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023

Figure 84 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023

Figure 85 : Frontage Labs.: Revenue Share, by Business Unit, FY 2023

Figure 86 : Frontage Labs.: Revenue Share, by Country/Region, FY 2023

Figure 87 : ICON plc: Revenue Share, by Country/Region, FY 2023

Figure 88 : IQVIA Inc: Revenue Share, by Business Unit, FY 2023

Figure 89 : IQVIA Inc: Revenue Share, by Country/Region, FY 2023

Figure 90 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023

Figure 91 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023

Figure 92 : Medpace: Revenue Share, by Business Unit, FY 2023

Figure 93 : Medpace: Revenue Share, by Country/Region, FY 2023

Figure 94 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023

Figure 95 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

Figure 96 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023

Figure 97 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧